Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Ketamine as an Adjuvant Therapy for Acute Vaso Occlusive Crisis in Pediatric Patients With Sickle Cell Disease, a Pilot Study

To see complete record on, please visit this link

Id: NCT02801292

Organisation Name: Augusta University

Overal Status: Unknown status

Start Date: July 2016

Last Update: June 15, 2016

Lead Sponsor: Augusta University

Brief Summary: The primary objective of the proposed study is to determine the potential role of Ketamine as an analgesic agent in pediatric sickle cell disease patients with refractory symptoms in acute (VOC).

  • Sickle Cell Disease

Total execution time in seconds: 0.29751586914062